Medicago receives 2009 Genesis Innovation Award
19-May-2009
- Canada
"We are pleased to have received yet another industry award which highlights our innovation behind the utilization of plants and VLPs for the production of vaccines," said Andy Sheldon, President and CEO of Medicago. "As we transition to a clinical company this year, we are proud that our mission to develop highly effective vaccines, rapidly and cost effectively, has been recognised through this award."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.